Broadfin Capital Has Trimmed Biodelivery Sciences Intl In (BDSI) Position By $1.42 Million; Last Week Paramount Resources Ltd. (TSE:POU) Coverage

January 14, 2018 - By Hazel Jackson

Broadfin Capital Llc decreased Biodelivery Sciences Intl In (BDSI) stake by 13.89% reported in 2017Q3 SEC filing. Broadfin Capital Llc sold 711,228 shares as Biodelivery Sciences Intl In (BDSI)’s stock rose 30.67%. The Broadfin Capital Llc holds 4.41 million shares with $13.01M value, down from 5.12 million last quarter. Biodelivery Sciences Intl In now has $157.87M valuation. The stock increased 0.89% or $0.025 during the last trading session, reaching $2.825. About 109,360 shares traded. BioDelivery Sciences International, Inc. (NASDAQ:BDSI) has risen 24.37% since January 14, 2017 and is uptrending. It has outperformed by 7.67% the S&P500.

Among 9 analysts covering Paramount Resources Ltd. (TSE:POU), 2 have Buy rating, 0 Sell and 7 Hold. Therefore 22% are positive. Paramount Resources Ltd. had 48 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Friday, August 7 by TD Securities. Dundee Securities downgraded Paramount Resources Ltd. (TSE:POU) on Tuesday, January 12 to “Neutral” rating. The rating was initiated by National Bank Canada on Tuesday, July 21 with “Outperform”. Credit Suisse maintained Paramount Resources Ltd. (TSE:POU) rating on Monday, August 22. Credit Suisse has “Neutral” rating and $13.50 target. Raymond James maintained Paramount Resources Ltd. (TSE:POU) on Friday, February 17 with “Strong Buy” rating. On Monday, August 10 the stock rating was maintained by FirstEnergy Capital with “Market Perform”. The firm earned “” rating on Monday, June 6 by Raymond James. The firm has “Outperform” rating given on Friday, November 18 by Scotia Capital. TD Securities maintained Paramount Resources Ltd. (TSE:POU) rating on Friday, March 10. TD Securities has “Hold” rating and $16 target. The firm has “Outperform” rating given on Thursday, November 5 by Raymond James. See Paramount Resources Ltd. (TSE:POU) latest ratings:

10/11/2017 Broker: Raymond James Rating: Strong Buy Old Target: $32.50 New Target: $36.00 Target Up
10/11/2017 Broker: RBC Capital Markets Rating: Sector Perform Old Target: $22.00 New Target: $27.00 Target Up
10/11/2017 Broker: Scotia Capital Rating: Sector Perform Old Target: $26.00 New Target: $28.00 Target Up
10/11/2017 Broker: TD Securities Rating: Hold Old Target: $23.00 New Target: $27.00 Target Up

Paramount Resources Ltd., an independent energy company, explores for, develops, produces, and markets crude oil, natural gas, and natural gas liquids in Canada. The company has market cap of $2.54 billion. The firm operates through three divisions: Principal Properties, Strategic Investments, and Corporate. It has a 4.07 P/E ratio. The Company’s principal properties are located in Alberta and British Columbia.

The stock increased 2.79% or $0.51 during the last trading session, reaching $18.78. About 451,934 shares traded or 17.95% up from the average. Paramount Resources Ltd. (TSE:POU) has 0.00% since January 14, 2017 and is . It has underperformed by 16.70% the S&P500.

Among 6 analysts covering BioDelivery Sciences International (NASDAQ:BDSI), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. BioDelivery Sciences International had 30 analyst reports since August 16, 2015 according to SRatingsIntel. Piper Jaffray maintained BioDelivery Sciences International, Inc. (NASDAQ:BDSI) rating on Thursday, May 12. Piper Jaffray has “Overweight” rating and $4 target. Roth Capital maintained the stock with “Buy” rating in Thursday, October 12 report. Janney Capital initiated BioDelivery Sciences International, Inc. (NASDAQ:BDSI) on Tuesday, October 27 with “Neutral” rating. The firm earned “Buy” rating on Friday, June 9 by H.C. Wainwright. The stock has “Buy” rating by Cantor Fitzgerald on Thursday, November 9. On Wednesday, May 11 the stock rating was downgraded by Cantor Fitzgerald to “Hold”. Cantor Fitzgerald maintained the stock with “Buy” rating in Monday, August 14 report. The rating was upgraded by Janney Capital on Friday, September 23 to “Buy”. The firm has “Buy” rating given on Wednesday, November 4 by Cantor Fitzgerald. The stock has “Buy” rating by H.C. Wainwright on Monday, July 24.

Investors sentiment increased to 1.67 in Q3 2017. Its up 0.67, from 1 in 2017Q2. It is positive, as 8 investors sold BDSI shares while 7 reduced holdings. 6 funds opened positions while 19 raised stakes. 20.34 million shares or 6.83% more from 19.04 million shares in 2017Q2 were reported. Wells Fargo And Mn stated it has 35,506 shares. Morgan Stanley holds 133,381 shares. Fny Managed Accounts Ltd Co accumulated 3,200 shares or 0.01% of the stock. Virtu Financial Llc invested in 26,601 shares or 0% of the stock. 585,200 are held by Renaissance Techs Limited Liability. Janney Montgomery Scott Lc reported 0% of its portfolio in BioDelivery Sciences International, Inc. (NASDAQ:BDSI). Baker Bros Advsrs LP invested 0.01% of its portfolio in BioDelivery Sciences International, Inc. (NASDAQ:BDSI). Jpmorgan Chase & Co invested in 39,467 shares. Art Advsrs Ltd Llc has 0.01% invested in BioDelivery Sciences International, Inc. (NASDAQ:BDSI) for 71,455 shares. 38,660 were reported by Cutter Brokerage Inc. 1,402 were accumulated by Royal Bancorporation Of Canada. State Street holds 51,562 shares or 0% of its portfolio. Broadfin Capital Ltd has 4.41 million shares. Salem Invest Counselors invested in 17,200 shares or 0.01% of the stock. Northern has 156,626 shares for 0% of their portfolio.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>